title: Human CD34+ CD133+ hematopoietic stem cells cultured with growth factors including Angptl5 efficiently engraft adult NOD-SCID Il2rγ-/- (NSG) mice.
abstract: Increasing demand for human hematopoietic stem cells (HSCs) in clinical and research applications necessitates expansion of HSCs in vitro. Before these cells can be used they must be carefully evaluated to assess their stem cell activity. Here, we expanded cord blood CD34(+) CD133(+) cells in a defined medium containing angiopoietin like 5 and insulin-like growth factor binding protein 2 and evaluated the cells for stem cell activity in NOD-SCID Il2rg(-/-) (NSG) mice by multi-lineage engraftment, long term reconstitution, limiting dilution and serial reconstitution. The phenotype of expanded cells was characterized by flow cytometry during the course of expansion and following engraftment in mice. We show that the SCID repopulating activity resides in the CD34(+) CD133(+) fraction of expanded cells and that CD34(+) CD133(+) cell number correlates with SCID repopulating activity before and after culture. The expanded cells mediate long-term hematopoiesis and serial reconstitution in NSG mice. Furthermore, they efficiently reconstitute not only neonate but also adult NSG recipients, generating human blood cell populations similar to those reported in mice reconstituted with uncultured human HSCs. These findings suggest an expansion of long term HSCs in our culture and show that expression of CD34 and CD133 serves as a marker for HSC activity in human cord blood cell cultures. The ability to expand human HSCs in vitro should facilitate clinical use of HSCs and large-scale construction of humanized mice from the same donor for research applications.
authors.affiliation: Koch Institute for Integrative Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
authors.forename: Adam C
authors.initials: AC
authors.lastname: Drake
authors.forename: Maroun
authors.initials: M
authors.lastname: Khoury
authors.forename: Ilya
authors.initials: I
authors.lastname: Leskov
authors.forename: Bettina P
authors.initials: BP
authors.lastname: Iliopoulou
authors.forename: Maria
authors.initials: M
authors.lastname: Fragoso
authors.forename: Harvey
authors.initials: H
authors.lastname: Lodish
authors.forename: Jianzhu
authors.initials: J
authors.lastname: Chen
mesh_terms: D000071916:AC133 Antigen; D000075802:Angiopoietin-like Proteins; D042682:Angiopoietins / Q000378:metabolism*; D000818:Animals; D015703:Antigens, CD / Q000096:biosynthesis*; D018952:Antigens, CD34 / Q000096:biosynthesis*; D001792:Blood Platelets / Q000378:metabolism; D005312:Fetal Blood / Q000378:metabolism; D005434:Flow Cytometry / Q000379:methods; D006023:Glycoproteins / Q000096:biosynthesis*; D006801:Humans; D053631:Interleukin Receptor Common gamma Subunit / Q000235:genetics*; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D008822:Mice, Transgenic; D010455:Peptides
chemical_list: D000071916:AC133 Antigen; C473567:ANGPTL5 protein, human; D000075802:Angiopoietin-like Proteins; D042682:Angiopoietins; D015703:Antigens, CD; D018952:Antigens, CD34; D006023:Glycoproteins; C507942:Il2rg protein, mouse; D053631:Interleukin Receptor Common gamma Subunit; C000606023:PROM1 protein, human; D010455:Peptides; C000606024:Prom1 protein, mouse